Sp986

PANEL DISCUSSION

Date
May 8, 2023
Explore related products in the following collection:

Society: AGA

GERD refractory to standard therapy is a common problem in clinical practice. The causes are multiple and there is a need for a rational evidence based approach to this problem. This session will focus on providing a clear definition of refractory GERD, potential etiologies, appropriate use of diagnostic testing and effective management strategies. LIVE STREAM SESSION

Presenters

Speaker Image for Arjan Bredenoord
Amsterdam UMC, University of Amsterdam
Speaker Image for David Armstrong
McMaster University
Speaker Image for Kristle Lynch
University of Pennsylvania
Speaker Image for Rena Yadlapati
University of California San Diego

Tracks

Related Products

Thumbnail for ESOPHAGUS
ESOPHAGUS
This session will have six talks on the indications, limitations, procedural and technical aspects on clinically useful GI physiology tests. The attendees will learn for which patients these test can be of value, and what type of results you can expect and how reliable these are…
Thumbnail for ESTIMATED BURDEN OF SCREENING FOR BARRETT’S ESOPHAGUS IN THE UNITED STATES
ESTIMATED BURDEN OF SCREENING FOR BARRETT’S ESOPHAGUS IN THE UNITED STATES
Barrett’s esophagus (BE), a pre-malignant precursor of esophageal adenocarcinoma (EAC), when recognized early through screening, could potentially allow for endoscopic surveillance or endoscopic eradication therapy…
Thumbnail for QUESTION AND ANSWER
QUESTION AND ANSWER
This session will provide an overview of the recent advances in diagnostic approaches to GERD, expansion in types and roles of diagnostic tools including ambulatory reflux monitoring, esophageal manometry, FLIP and MI in regards to GERD, and updates in guidelines and best practice advice…
Thumbnail for NOVEL CLINICAL RISK PREDICTION SCORE FOR LARYNGOPHARYNGEAL REFLUX
NOVEL CLINICAL RISK PREDICTION SCORE FOR LARYNGOPHARYNGEAL REFLUX
Discerning whether laryngeal symptoms are related to reflux (laryngopharyngeal reflux; LPR) is a challenge. Consequently, patients see numerous specialists, undergo multiple diagnostic tests and empirically trial proton pump inhibitors (PPIs), often with inconsistent response…